 | • レポートコード：MRC2-11QY11185 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脳腫瘍治療のグローバル市場について調査・分析したレポートです。種類別（外科、放射線療法、化学療法、免疫療法、その他）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脳腫瘍治療の競争状況、市場シェア ・世界の脳腫瘍治療市場：種類別市場規模 2015年-2020年（外科、放射線療法、化学療法、免疫療法、その他） ・世界の脳腫瘍治療市場：種類別市場規模予測 2021年-2026年（外科、放射線療法、化学療法、免疫療法、その他） ・世界の脳腫瘍治療市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界の脳腫瘍治療市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米の脳腫瘍治療市場分析：米国、カナダ ・ヨーロッパの脳腫瘍治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脳腫瘍治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脳腫瘍治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脳腫瘍治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Genetech (U.S.)、Bristol Mayers Squibb (U.S.)、Hoffman-La Roche (Switzerland)、Astra Zeneca (India)、Pfizer (U.S.)、Novartis (Switzerland)、Antisenese Pharma (Mongolia)、Merck (U.S.)、Mcleod’s Pharmaceuticals (India)、Mankind Pharma (India)、Dr. Reddy’s Laboratories (India) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient’s age and general health.
Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms and slow down the tumor’s growth.
Market Analysis and Insights: Global Brain Tumor Treatment Market
The global Brain Tumor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Brain Tumor Treatment Scope and Market Size
Brain Tumor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brain Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Genetech (U.S.)
Bristol Mayers Squibb (U.S.)
Hoffman-La Roche (Switzerland)
Astra Zeneca (India)
Pfizer (U.S.)
Novartis (Switzerland)
Antisenese Pharma (Mongolia)
Merck (U.S.)
Mcleod’s Pharmaceuticals (India)
Mankind Pharma (India)
Dr. Reddy’s Laboratories (India)
Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Others
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brain Tumor Treatment Revenue
1.4 Market by Type
1.4.1 Global Brain Tumor Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Chemotherapy
1.4.5 Immunotherapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Brain Tumor Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Treatment Market Perspective (2015-2026)
2.2 Global Brain Tumor Treatment Growth Trends by Regions
2.2.1 Brain Tumor Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Brain Tumor Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Brain Tumor Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Brain Tumor Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Brain Tumor Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Treatment Players by Market Size
3.1.1 Global Top Brain Tumor Treatment Players by Revenue (2015-2020)
3.1.2 Global Brain Tumor Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Brain Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brain Tumor Treatment Market Concentration Ratio
3.2.1 Global Brain Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Brain Tumor Treatment Revenue in 2019
3.3 Brain Tumor Treatment Key Players Head office and Area Served
3.4 Key Players Brain Tumor Treatment Product Solution and Service
3.5 Date of Enter into Brain Tumor Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Brain Tumor Treatment Historic Market Size by Type (2015-2020)
4.2 Global Brain Tumor Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Brain Tumor Treatment Market Size by Application (2015-2020)
5.2 Global Brain Tumor Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Brain Tumor Treatment Market Size (2015-2020)
6.2 Brain Tumor Treatment Key Players in North America (2019-2020)
6.3 North America Brain Tumor Treatment Market Size by Type (2015-2020)
6.4 North America Brain Tumor Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Brain Tumor Treatment Market Size (2015-2020)
7.2 Brain Tumor Treatment Key Players in Europe (2019-2020)
7.3 Europe Brain Tumor Treatment Market Size by Type (2015-2020)
7.4 Europe Brain Tumor Treatment Market Size by Application (2015-2020)
8 China
8.1 China Brain Tumor Treatment Market Size (2015-2020)
8.2 Brain Tumor Treatment Key Players in China (2019-2020)
8.3 China Brain Tumor Treatment Market Size by Type (2015-2020)
8.4 China Brain Tumor Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Brain Tumor Treatment Market Size (2015-2020)
9.2 Brain Tumor Treatment Key Players in Japan (2019-2020)
9.3 Japan Brain Tumor Treatment Market Size by Type (2015-2020)
9.4 Japan Brain Tumor Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Brain Tumor Treatment Market Size (2015-2020)
10.2 Brain Tumor Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Brain Tumor Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Brain Tumor Treatment Market Size by Application (2015-2020)
11 India
11.1 India Brain Tumor Treatment Market Size (2015-2020)
11.2 Brain Tumor Treatment Key Players in India (2019-2020)
11.3 India Brain Tumor Treatment Market Size by Type (2015-2020)
11.4 India Brain Tumor Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Brain Tumor Treatment Market Size (2015-2020)
12.2 Brain Tumor Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Brain Tumor Treatment Market Size by Type (2015-2020)
12.4 Central & South America Brain Tumor Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Genetech (U.S.)
13.1.1 Genetech (U.S.) Company Details
13.1.2 Genetech (U.S.) Business Overview
13.1.3 Genetech (U.S.) Brain Tumor Treatment Introduction
13.1.4 Genetech (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020))
13.1.5 Genetech (U.S.) Recent Development
13.2 Bristol Mayers Squibb (U.S.)
13.2.1 Bristol Mayers Squibb (U.S.) Company Details
13.2.2 Bristol Mayers Squibb (U.S.) Business Overview
13.2.3 Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Introduction
13.2.4 Bristol Mayers Squibb (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020)
13.2.5 Bristol Mayers Squibb (U.S.) Recent Development
13.3 Hoffman-La Roche (Switzerland)
13.3.1 Hoffman-La Roche (Switzerland) Company Details
13.3.2 Hoffman-La Roche (Switzerland) Business Overview
13.3.3 Hoffman-La Roche (Switzerland) Brain Tumor Treatment Introduction
13.3.4 Hoffman-La Roche (Switzerland) Revenue in Brain Tumor Treatment Business (2015-2020)
13.3.5 Hoffman-La Roche (Switzerland) Recent Development
13.4 Astra Zeneca (India)
13.4.1 Astra Zeneca (India) Company Details
13.4.2 Astra Zeneca (India) Business Overview
13.4.3 Astra Zeneca (India) Brain Tumor Treatment Introduction
13.4.4 Astra Zeneca (India) Revenue in Brain Tumor Treatment Business (2015-2020)
13.4.5 Astra Zeneca (India) Recent Development
13.5 Pfizer (U.S.)
13.5.1 Pfizer (U.S.) Company Details
13.5.2 Pfizer (U.S.) Business Overview
13.5.3 Pfizer (U.S.) Brain Tumor Treatment Introduction
13.5.4 Pfizer (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020)
13.5.5 Pfizer (U.S.) Recent Development
13.6 Novartis (Switzerland)
13.6.1 Novartis (Switzerland) Company Details
13.6.2 Novartis (Switzerland) Business Overview
13.6.3 Novartis (Switzerland) Brain Tumor Treatment Introduction
13.6.4 Novartis (Switzerland) Revenue in Brain Tumor Treatment Business (2015-2020)
13.6.5 Novartis (Switzerland) Recent Development
13.7 Antisenese Pharma (Mongolia)
13.7.1 Antisenese Pharma (Mongolia) Company Details
13.7.2 Antisenese Pharma (Mongolia) Business Overview
13.7.3 Antisenese Pharma (Mongolia) Brain Tumor Treatment Introduction
13.7.4 Antisenese Pharma (Mongolia) Revenue in Brain Tumor Treatment Business (2015-2020)
13.7.5 Antisenese Pharma (Mongolia) Recent Development
13.8 Merck (U.S.)
13.8.1 Merck (U.S.) Company Details
13.8.2 Merck (U.S.) Business Overview
13.8.3 Merck (U.S.) Brain Tumor Treatment Introduction
13.8.4 Merck (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020)
13.8.5 Merck (U.S.) Recent Development
13.9 Mcleod’s Pharmaceuticals (India)
13.9.1 Mcleod’s Pharmaceuticals (India) Company Details
13.9.2 Mcleod’s Pharmaceuticals (India) Business Overview
13.9.3 Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Introduction
13.9.4 Mcleod’s Pharmaceuticals (India) Revenue in Brain Tumor Treatment Business (2015-2020)
13.9.5 Mcleod’s Pharmaceuticals (India) Recent Development
13.10 Mankind Pharma (India)
13.10.1 Mankind Pharma (India) Company Details
13.10.2 Mankind Pharma (India) Business Overview
13.10.3 Mankind Pharma (India) Brain Tumor Treatment Introduction
13.10.4 Mankind Pharma (India) Revenue in Brain Tumor Treatment Business (2015-2020)
13.10.5 Mankind Pharma (India) Recent Development
13.11 Dr. Reddy’s Laboratories (India)
10.11.1 Dr. Reddy’s Laboratories (India) Company Details
10.11.2 Dr. Reddy’s Laboratories (India) Business Overview
10.11.3 Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Introduction
10.11.4 Dr. Reddy’s Laboratories (India) Revenue in Brain Tumor Treatment Business (2015-2020)
10.11.5 Dr. Reddy’s Laboratories (India) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Brain Tumor Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Brain Tumor Treatment Revenue
Table 3. Ranking of Global Top Brain Tumor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Brain Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Radiation Therapy
Table 7. Key Players of Chemotherapy
Table 8. Key Players of Immunotherapy
Table 9. Key Players of Others
Table 10. Global Brain Tumor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Brain Tumor Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Brain Tumor Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Brain Tumor Treatment Market Share by Regions (2015-2020)
Table 14. Global Brain Tumor Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Brain Tumor Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Brain Tumor Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Brain Tumor Treatment Players
Table 21. Global Brain Tumor Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Brain Tumor Treatment Market Share by Players (2015-2020)
Table 23. Global Top Brain Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Treatment as of 2019)
Table 24. Global Brain Tumor Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Brain Tumor Treatment Product Solution and Service
Table 27. Date of Enter into Brain Tumor Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Brain Tumor Treatment Market Size Share by Type (2015-2020)
Table 31. Global Brain Tumor Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Brain Tumor Treatment Market Size Share by Application (2015-2020)
Table 33. Global Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Brain Tumor Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Brain Tumor Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Brain Tumor Treatment Market Share (2019-2020)
Table 37. North America Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Brain Tumor Treatment Market Share by Type (2015-2020)
Table 39. North America Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Brain Tumor Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Brain Tumor Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Brain Tumor Treatment Market Share (2019-2020)
Table 43. Europe Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Brain Tumor Treatment Market Share by Type (2015-2020)
Table 45. Europe Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Brain Tumor Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Brain Tumor Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Brain Tumor Treatment Market Share (2019-2020)
Table 49. China Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Brain Tumor Treatment Market Share by Type (2015-2020)
Table 51. China Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Brain Tumor Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Brain Tumor Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Brain Tumor Treatment Market Share (2019-2020)
Table 55. Japan Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Brain Tumor Treatment Market Share by Type (2015-2020)
Table 57. Japan Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Brain Tumor Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Brain Tumor Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Brain Tumor Treatment Market Share (2019-2020)
Table 61. Southeast Asia Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Brain Tumor Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Brain Tumor Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Brain Tumor Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Brain Tumor Treatment Market Share (2019-2020)
Table 67. India Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Brain Tumor Treatment Market Share by Type (2015-2020)
Table 69. India Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Brain Tumor Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Brain Tumor Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Brain Tumor Treatment Market Share (2019-2020)
Table 73. Central & South America Brain Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Brain Tumor Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Brain Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Brain Tumor Treatment Market Share by Application (2015-2020)
Table 77. Genetech (U.S.) Company Details
Table 78. Genetech (U.S.) Business Overview
Table 79. Genetech (U.S.) Product
Table 80. Genetech (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 81. Genetech (U.S.) Recent Development
Table 82. Bristol Mayers Squibb (U.S.) Company Details
Table 83. Bristol Mayers Squibb (U.S.) Business Overview
Table 84. Bristol Mayers Squibb (U.S.) Product
Table 85. Bristol Mayers Squibb (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 86. Bristol Mayers Squibb (U.S.) Recent Development
Table 87. Hoffman-La Roche (Switzerland) Company Details
Table 88. Hoffman-La Roche (Switzerland) Business Overview
Table 89. Hoffman-La Roche (Switzerland) Product
Table 90. Hoffman-La Roche (Switzerland) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 91. Hoffman-La Roche (Switzerland) Recent Development
Table 92. Astra Zeneca (India) Company Details
Table 93. Astra Zeneca (India) Business Overview
Table 94. Astra Zeneca (India) Product
Table 95. Astra Zeneca (India) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 96. Astra Zeneca (India) Recent Development
Table 97. Pfizer (U.S.) Company Details
Table 98. Pfizer (U.S.) Business Overview
Table 99. Pfizer (U.S.) Product
Table 100. Pfizer (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 101. Pfizer (U.S.) Recent Development
Table 102. Novartis (Switzerland) Company Details
Table 103. Novartis (Switzerland) Business Overview
Table 104. Novartis (Switzerland) Product
Table 105. Novartis (Switzerland) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 106. Novartis (Switzerland) Recent Development
Table 107. Antisenese Pharma (Mongolia) Company Details
Table 108. Antisenese Pharma (Mongolia) Business Overview
Table 109. Antisenese Pharma (Mongolia) Product
Table 110. Antisenese Pharma (Mongolia) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 111. Antisenese Pharma (Mongolia) Recent Development
Table 112. Merck (U.S.) Business Overview
Table 113. Merck (U.S.) Product
Table 114. Merck (U.S.) Company Details
Table 115. Merck (U.S.) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 116. Merck (U.S.) Recent Development
Table 117. Mcleod’s Pharmaceuticals (India) Company Details
Table 118. Mcleod’s Pharmaceuticals (India) Business Overview
Table 119. Mcleod’s Pharmaceuticals (India) Product
Table 120. Mcleod’s Pharmaceuticals (India) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 121. Mcleod’s Pharmaceuticals (India) Recent Development
Table 122. Mankind Pharma (India) Company Details
Table 123. Mankind Pharma (India) Business Overview
Table 124. Mankind Pharma (India) Product
Table 125. Mankind Pharma (India) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 126. Mankind Pharma (India) Recent Development
Table 127. Dr. Reddy’s Laboratories (India) Company Details
Table 128. Dr. Reddy’s Laboratories (India) Business Overview
Table 129. Dr. Reddy’s Laboratories (India) Product
Table 130. Dr. Reddy’s Laboratories (India) Revenue in Brain Tumor Treatment Business (2015-2020) (Million US$)
Table 131. Dr. Reddy’s Laboratories (India) Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Tumor Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Radiation Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Others Features
Figure 7. Global Brain Tumor Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Brain Tumor Treatment Report Years Considered
Figure 11. Global Brain Tumor Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Brain Tumor Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Brain Tumor Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Brain Tumor Treatment Market Share by Players in 2019
Figure 16. Global Top Brain Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Brain Tumor Treatment Revenue in 2019
Figure 18. North America Brain Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Brain Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Brain Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Brain Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Brain Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Brain Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Brain Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
脳腫瘍治療薬の世界市場（～2026年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…- 小児脳腫瘍の世界市場（～2026年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…
- 脳腫瘍診断・治療の世界市場（～2026年） With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing. Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market The global Brain Tumo…
- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
- 外傷性脳損傷治療の世界市場（～2026年） Traumatic brain injury usually results from a violent blow or jolt to the head or body. Market Analysis and Insights: Global Traumatic Brain Injuries Treatment Market The global Traumatic Brain Injuries Treatment market size is projected to reach US$ 2178.1 million by 2026, from US$ 2112.1 million i…